GHCM
NVO

Glen Harbor Capital Management’s Novo Nordisk NVO Stock Holding History

Glen Harbor Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-22,616
Closed -$533K – 1326
2018
Q3 		$533K Hold
22,616
– – 0.01% 699
2018
Q2 		$522K Hold
22,616
– – 0.01% 629
2018
Q1 		$557K Hold
22,616
– – 0.01% 598
2017
Q4 		$607K Hold
22,616
– – 0.01% 581
2017
Q3 		$544K Hold
22,616
– – 0.01% 572
2017
Q2 		$485K Hold
22,616
– – 0.01% 606
2017
Q1 		$388K Hold
22,616
– – 0.01% 620
2016
Q4 		$405K Buy
+22,616
New +$410K 0.01% 555

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Glen Harbor Capital Management's NVO Position: Q4 2018 in Review

Glen Harbor Capital Management sold out of Novo Nordisk (NVO) in Q4 2018, closing a stake of 22,616 shares — an estimated $533K sold.

Glen Harbor Capital Management first reported a position in NVO in Q4 2016 and held it in 8 quarters. The position peaked at $607K in Q4 2017. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.

  • Glen Harbor Capital Management reported no remaining Novo Nordisk position as of Q4 2018 after selling out during the quarter.
  • Glen Harbor Capital Management sold 22,616 Novo Nordisk shares in Q4 2018, an estimated $533K.
  • Glen Harbor Capital Management first reported a position in Novo Nordisk in Q4 2016 and held it in 8 quarters.
  • Glen Harbor Capital Management's Novo Nordisk position peaked at $607K in Q4 2017.
  • 550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.

Based on Glen Harbor Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.